All 6 Debates between Lucy Frazer and Rob Butler

Wed 2nd Dec 2020
Prisons (Substance Testing) Bill
Public Bill Committees

Committee stage 2 December 2020 & Committee Debate 2 December 2020: House of Commons

Oral Answers to Questions

Debate between Lucy Frazer and Rob Butler
Thursday 22nd February 2024

(1 month, 3 weeks ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Rob Butler Portrait Rob Butler (Aylesbury) (Con)
- Hansard - - - Excerpts

1. Whether she has had recent discussions with the BBC board on the implementation of recommendations in the BBC mid-term review.

Lucy Frazer Portrait The Secretary of State for Culture, Media and Sport (Lucy Frazer)
- Parliament Live - Hansard - -

The BBC is a hugely valued institution, and the mid-term review seeks to ensure that it continues to provide an outstanding service by improving its processes in relation to both impartiality and complaints. I regularly meet the BBC’s chair and director-general, and I will continue to use those meetings to raise these important issues.

Rob Butler Portrait Rob Butler
- Parliament Live - Hansard - - - Excerpts

I started my career as a BBC reporter, and I firmly believe in the importance of our national broadcaster being both independent, particularly at moments and eras such as this, and completely impartial. However, every year, many people complain that the BBC is not as impartial as it should be, even that it is biased, and the BBC then dismisses the vast majority of those complaints. Does my right hon. and learned Friend think that the public would perhaps have more confidence in how those complaints are investigated if they were investigated independently from the outset?

Lucy Frazer Portrait Lucy Frazer
- Parliament Live - Hansard - -

My hon. Friend is absolutely right. The public rightly expect the BBC to be an exemplar of impartiality. Our review highlighted issues in relation to both impartiality and complaints. As a result, the BBC will undertake significant reforms on both impartiality and complaints. At the charter review, as I have already said, we will examine whether the BBC first process remains the right complaints model.

Oral Answers to Questions

Debate between Lucy Frazer and Rob Butler
Thursday 11th January 2024

(3 months, 1 week ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lucy Frazer Portrait Lucy Frazer
- Parliament Live - Hansard - -

I know that my hon. Friend is himself a veteran of the silver screen, appearing in the brilliant British “House of Cards”. Our film industry is world leading. He is right that the strikes caused disruption. We work very closely with our partners in other jurisdictions. One example is the international hit film “Barbie”, which was filmed in the UK, supported 750 jobs, added £80 million to our economy and earned more than £1.1 billion at the global box office. We needed to ensure that the film industry could continue to thrive after the strikes, which is why we are continuing to support the industry with tax incentives, funding pots and, importantly, the development of a skills pipeline to ensure success long into the future.

Rob Butler Portrait Rob Butler (Aylesbury) (Con)
- Hansard - - - Excerpts

10. Whether she has had recent discussions with the BBC Board on the impartiality of the BBC’s current affairs coverage.

Prisons (Substance Testing) Bill

Debate between Lucy Frazer and Rob Butler
Committee stage & Committee Debate 2 December 2020: House of Commons
Wednesday 2nd December 2020

(3 years, 4 months ago)

Public Bill Committees
Read Full debate Prisons (Substance Testing) Act 2021 View all Prisons (Substance Testing) Act 2021 Debates Read Hansard Text Read Debate Ministerial Extracts Amendment Paper: Public Bill Committee Amendments as at 2 December 2020 - (2 Dec 2020)
Lucy Frazer Portrait Lucy Frazer
- Hansard - -

The hon. Member for West Ham has highlighted two matters in her amendment, both of which relate to reporting. I am very grateful for her having raised these very important matters, but I would like to reassure her that the amendment is not necessary, because sufficient procedures are already in place to measure and record what work will be done.

I would like to highlight, as the hon. Lady has, that making sure treatment is available is critical, and the first step is this one: identifying what substances are out there. The second step is identifying those people who we need to help, and the third is to give treatment. I hope that in the points I raised in response to her earlier speech, I have identified the considerable measures that we are taking to support people in their treatment, including the significant sums we are giving to rough sleepers—of course, there is an overlap there with prison leavers—and the RECONNECT service that the NHS links up with those treatments within prison and in the community.

I would like to go through the substance of the amendment. Through proposed new clause 1, the hon. Lady is seeking to expand the current scope of reporting by obligating an assessment of value for money after a year, so I will identify the structures that are already in place. As I said, the key objective is to ensure that people are identified, so that they can get treatments, and the effectiveness of that objective is continually reviewed as part of the national prison drugs strategy, which we published in April last year.

The Department also released an annual assessment, with accompanying statistics, as part of HMPPS’s annual digest. This provides a number of the items that the hon. Lady has enumerated in her amendment, including the number of tests conducted, the number of positive tests, and the number of psychoactive substances found. Furthermore, we believe that the contract for providing the drug testing service is effectively managed and reviewed by operational and commercial teams through regular formal contract meetings. To understand the capabilities of the various testing providers, HMPPS has undertaken extensive market engagement with potential suppliers, and it will do so again during future contract tendering processes.

In relation to the specific points the shadow Minister made about value for money, I can reassure her that the provisions in the Bill would contribute to value for money through drug testing in prisons and ensuring that complete information is routinely gathered relating to the misuse of substances in custody. This, as I said, will enable us to make the right operational responses, as well as ensure that we get the right interventions. I believe that there is scrutiny for drug testing in prisons, supported by existing processes, and we should not rush into legislating on this issue.

I would, of course, be happy to write to the hon. Lady when the annual digest is published—I believe the next one is due in July—to draw her attention to those matters, so that she gets that material as quickly and speedily as possible. Of course, I am always happy to engage with her when she has questions, so that we can resolve any issues that she feels have not been fully dealt with. I ask her to withdraw new clause 1.

10.30 am

In new clause 2, the hon. Lady is asking that the Advisory Council on the Misuse of Drugs make biannual reports to Parliament on substance testing in prisons—that is quite similar to new clause 1. As I have explained to the Committee, the effectiveness of drug testing is continuously reviewed and the contract in which it sits is already scrutinised.

Officials at the Advisory Council on the Misuse of Drugs have advised us that the council is not set up for the type of role proposed in the new clause, which appears to be about reporting on the operations and performance of the substance testing system. The council’s role is to provide independent science advice to the Government. That may involve, for example, synthesising advice based on evidence collected on misuse and societal harms. Its role is not to report on the objectives of specific drug testing programmes. I can reassure the shadow Minister, however, that the ACMD already has a role in making recommendations for action, but more broadly, under its role in the Misuse of Drugs Act 1971. The new clause would broaden those functions beyond their current scope.

I will address a few of the specific points that the hon. Lady made and I hope that I can alleviate some of her concerns. She identified and mentioned the significant investment that we are making in security—the £100 million investment to which I referred earlier when addressing the main clauses. In the course of that significant programme and of ensuring that we have funding from the Treasury for it, we have identified where we think, having done some work, the best value for money is. That is why we are pursuing those measures in the course of our programme.

The hon. Lady talked about the impact of covid on drug testing and the importance of lessons learned. I completely agree with her about the importance of looking at what we have learned in this period, and we are undertaking a broad study on that, with input from a wide range of people, including service users, third parties, and HMPPS itself. We suspended drug testing between April and June because of the social distancing measures and the lockdown within prisons, but under our current national framework prisons can reintroduce testing. Where that is done, prisons must take account of social distancing and cohorting measures. At the moment, it is too early to evaluate the impact of the changes on the drug testing programme, but we will of course be looking at all those issues in due course.

Rob Butler Portrait Rob Butler
- Hansard - - - Excerpts

On the point about the impact of covid, will the Minister join me in paying tribute to all the staff in HMPPS—the officers, the staff in prisons, the governors and those at HMPPS head office—for their tremendous effort to minimise and mitigate the effect of covid on the prison estate during the pandemic?

Lucy Frazer Portrait Lucy Frazer
- Hansard - -

I absolutely join my hon. Friend in that. He makes an important point: at HMPPS, the governors, prison officers and all the staff in the service have done such a remarkable job through extremely challenging times. The statistics show that we were looking at a significant number of deaths—2,500 to 3,500 deaths—and in the first wave, the death count was in the mid-20s. Although all those deaths are, of course, very sad, that figure is a credit to the joined-up working at every level, including with the POA. Again, I put on the record my thanks to them for the constructive way that they have engaged; I know that they are tired and that it is difficult.

I am very pleased with this morning’s news about the vaccine, because we can see some light at the end of the tunnel of this very difficult period. While many people will be celebrating Christmas, many of our prison officers will still be on the wings doing their work. I pay tribute to them for all the work that they have already done and for the work that I know that they will do, unrelentingly, over the next three months. May I say that I do not find that my hon. Friend the Member for Aylesbury only does PMQs? He is a regular participant in all justice matters, and it is a pleasure to see him serving on the Committee.

I make one last point to the hon. Member for West Ham. She made some important points about who we will give the information to and how it will be used. Like her, I agree that once we collect information, we should use it to our best advantage. We will look very closely at her suggestion that the information be widely shared and see what we can do to share that data within prisons.

My understanding is that we do currently share some of the prevalence data with the POA for substances that have already been tested for. Of course, we need to ensure that we respect security and that we do the right thing in terms of policy making, but that is something that I am very happy to look at further. She also mentioned sharing data with the NHS. We will, of course, be sharing our insights with healthcare providers so that they can quicker adapt their services.

I am always happy to engage with the hon. Lady, as she knows, on these and any other matters, but I ask her to withdraw the new clause.

Prisons (Substance Testing) Bill

Debate between Lucy Frazer and Rob Butler
Wednesday 2nd December 2020

(3 years, 4 months ago)

Public Bill Committees
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lucy Frazer Portrait Lucy Frazer
- Hansard - -

The hon. Member for West Ham has highlighted two matters in her amendment, both of which relate to reporting. I am very grateful for her having raised these very important matters, but I would like to reassure her that the amendment is not necessary, because sufficient procedures are already in place to measure and record what work will be done.

I would like to highlight, as the hon. Lady has, that making sure treatment is available is critical, and the first step is this one: identifying what substances are out there. The second step is identifying those people who we need to help, and the third is to give treatment. I hope that in the points I raised in response to her earlier speech, I have identified the considerable measures that we are taking to support people in their treatment, including the significant sums we are giving to rough sleepers—of course, there is an overlap there with prison leavers—and the RECONNECT service that the NHS links up with those treatments within prison and in the community.

I would like to go through the substance of the amendment. Through proposed new clause 1, the hon. Lady is seeking to expand the current scope of reporting by obligating an assessment of value for money after a year, so I will identify the structures that are already in place. As I said, the key objective is to ensure that people are identified, so that they can get treatments, and the effectiveness of that objective is continually reviewed as part of the national prison drugs strategy, which we published in April last year.

The Department also released an annual assessment, with accompanying statistics, as part of HMPPS’s annual digest. This provides a number of the items that the hon. Lady has enumerated in her amendment, including the number of tests conducted, the number of positive tests, and the number of psychoactive substances found. Furthermore, we believe that the contract for providing the drug testing service is effectively managed and reviewed by operational and commercial teams through regular formal contract meetings. To understand the capabilities of the various testing providers, HMPPS has undertaken extensive market engagement with potential suppliers, and it will do so again during future contract tendering processes.

In relation to the specific points the shadow Minister made about value for money, I can reassure her that the provisions in the Bill would contribute to value for money through drug testing in prisons and ensuring that complete information is routinely gathered relating to the misuse of substances in custody. This, as I said, will enable us to make the right operational responses, as well as ensure that we get the right interventions. I believe that there is scrutiny for drug testing in prisons, supported by existing processes, and we should not rush into legislating on this issue.

I would, of course, be happy to write to the hon. Lady when the annual digest is published—I believe the next one is due in July—to draw her attention to those matters, so that she gets that material as quickly and speedily as possible. Of course, I am always happy to engage with her when she has questions, so that we can resolve any issues that she feels have not been fully dealt with. I ask her to withdraw new clause 1.

10.30 am

In new clause 2, the hon. Lady is asking that the Advisory Council on the Misuse of Drugs make biannual reports to Parliament on substance testing in prisons—that is quite similar to new clause 1. As I have explained to the Committee, the effectiveness of drug testing is continuously reviewed and the contract in which it sits is already scrutinised.

Officials at the Advisory Council on the Misuse of Drugs have advised us that the council is not set up for the type of role proposed in the new clause, which appears to be about reporting on the operations and performance of the substance testing system. The council’s role is to provide independent science advice to the Government. That may involve, for example, synthesising advice based on evidence collected on misuse and societal harms. Its role is not to report on the objectives of specific drug testing programmes. I can reassure the shadow Minister, however, that the ACMD already has a role in making recommendations for action, but more broadly, under its role in the Misuse of Drugs Act 1971. The new clause would broaden those functions beyond their current scope.

I will address a few of the specific points that the hon. Lady made and I hope that I can alleviate some of her concerns. She identified and mentioned the significant investment that we are making in security—the £100 million investment to which I referred earlier when addressing the main clauses. In the course of that significant programme and of ensuring that we have funding from the Treasury for it, we have identified where we think, having done some work, the best value for money is. That is why we are pursuing those measures in the course of our programme.

The hon. Lady talked about the impact of covid on drug testing and the importance of lessons learned. I completely agree with her about the importance of looking at what we have learned in this period, and we are undertaking a broad study on that, with input from a wide range of people, including service users, third parties, and HMPPS itself. We suspended drug testing between April and June because of the social distancing measures and the lockdown within prisons, but under our current national framework prisons can reintroduce testing. Where that is done, prisons must take account of social distancing and cohorting measures. At the moment, it is too early to evaluate the impact of the changes on the drug testing programme, but we will of course be looking at all those issues in due course.

Rob Butler Portrait Rob Butler
- Hansard - - - Excerpts

On the point about the impact of covid, will the Minister join me in paying tribute to all the staff in HMPPS—the officers, the staff in prisons, the governors and those at HMPPS head office—for their tremendous effort to minimise and mitigate the effect of covid on the prison estate during the pandemic?

Oral Answers to Questions

Debate between Lucy Frazer and Rob Butler
Tuesday 22nd September 2020

(3 years, 7 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lucy Frazer Portrait Lucy Frazer
- Hansard - -

As I mentioned, we have increased the number of staff in the public sector. We have also introduced the key worker scheme, which is essential for staff to liaise with the prisoners. Private prisons perform well, as do public prisons. Recent reports from this year for HMP Parc and HMP Rye Hill, which are both managed by G4S, judged both to be good. There is not a mantra that public is good, private is bad; both work well.

Rob Butler Portrait Rob Butler (Aylesbury) (Con)
- Hansard - - - Excerpts

What steps his Department is taking to reduce reoffending. [R]

Mark Fletcher Portrait Mark Fletcher (Bolsover) (Con)
- Hansard - - - Excerpts

What steps his Department is taking to reduce reoffending.

Lucy Frazer Portrait The Minister of State, Ministry of Justice (Lucy Frazer)
- Hansard - -

Reoffending rates are too high, resulting in some individuals repeatedly posing a danger to their communities and the undermining of public confidence in the criminal justice system. Last week, we published the sentencing White Paper, which sets out measures to better supervise and support offenders following their release from custody. It includes proposals for changes to the rehabilitation periods set out in the Rehabilitation of Offenders Act 1974, to improve access to employment and education for those with criminal records.

Rob Butler Portrait Rob Butler
- Hansard - - - Excerpts

I recently visited MTCnovo’s hub for offenders from Aylesbury and was impressed by the dedication and commitment of the staff, as well as of those completing their sentences there. Does my hon. and learned Friend agree that a vital element of reducing reoffending is having enough well-trained and skilled probation officers who can thoroughly oversee and supervise sentences?

Lucy Frazer Portrait Lucy Frazer
- Hansard - -

I absolutely agree with my hon. Friend. I thank all the staff at MTCnovo and Thames Valley community rehabilitation company. My hon. Friend is absolutely right to say that dedicated prison officers are a key part of reducing reoffending, which is why last month we launched the probation workforce strategy, setting out our commitment to recruit an additional 1,000 probation officers by the end of January next year. It is about not just recruiting staff but how we work with them and invest in their skills. We will be focusing on their skills, recruitment, retention, diversity, leadership and wellbeing.

Oral Answers to Questions

Debate between Lucy Frazer and Rob Butler
Tuesday 25th February 2020

(4 years, 1 month ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Rob Butler Portrait Rob Butler (Aylesbury) (Con)
- Hansard - - - Excerpts

The prisons inspectorate has this morning published its latest report into Her Majesty’s Young Offender Institution Aylesbury. I very much welcome the progress that has been made, and pay tribute to the governor and her staff for that, but there is still a great deal to do. Will my hon. and learned Friend commit to providing the resources that will be necessary to implement all the recommendations of the report?

Lucy Frazer Portrait Lucy Frazer
- Hansard - -

We are very conscious of the state of Aylesbury. We are bringing two wings back online by the beginning of next year and remain committed to making improvements in that prison.